Article Text

Original research
Primary care for people with severe mental illness and comorbid obstructive airways disease: a qualitative study of patient perspectives with integrated stakeholder feedback
  1. Caroline Mitchell1,
  2. Nicholas Zuraw1,
  3. Brigitte Delaney1,
  4. Helen Twohig2,
  5. Neil Dolan1,
  6. Elizabeth Walton1,
  7. Joe Hulin3,
  8. Camelia Yousefpour4
  1. 1Academic Unit of Primary Medical Care, The University of Sheffield, Sheffield, UK
  2. 2Institute for Primary Health Care and Health Sciences, Keele University, Keele, Staffordshire, UK
  3. 3Mental Health, Research Unit, Sheffield School of Health and Related Research, University of Sheffield, Sheffield, UK
  4. 4Academic Unit of Primary Medical Care, The University of Sheffield Faculty of Medicine Dentistry and Health, Sheffield, UK
  1. Correspondence to Dr Caroline Mitchell; c.mitchell{at}sheffield.ac.uk

Abstract

Objectives To explore patient and stakeholder perspectives on primary respiratory care for people with severe mental illness (SMI) and comorbid obstructive airways disease (OAD).

Design Qualitative, semistructured qualitative interviews were undertaken with a purposive sample of people with a diagnosis of SMI (bipolar illness, schizophrenia, affective disorder with psychosis) and comorbid asthma or chronic obstructive pulmonary disease. Transcribed data were analysed using an interpretive phenomenological approach. Study results were discussed with stakeholders.

Setting Eight UK general practices.

Participants 16 people aged 45–75 years, with SMI and comorbid asthma or chronic obstructive pulmonary disease, were interviewed. Twenty-one people, four with lived experience of SMI and seventeen health/social care/third sector practitioners, participated in discussion groups at a stakeholder event.

Results Participants described disability and isolation arising from the interplay of SMI and OAD symptoms. Social support determined ease of access to primary care. Self-management of respiratory health was not person-centred as practitioners failed to consider individual needs and health literacy. Participants perceived smoking cessation impossible without tailored support. Less than half of the practices facilitated personalised access to timely primary care and continuity. Overall, there was a reliance on urgent care if service adaptations and social support were lacking. The stakeholder group expressed concern about gaps in care, the short-term funding of community organisations and fear of loss of benefits. Potential solutions focused on supported navigation of care pathways, relational continuity, individual and community asset building and the evolving social prescriber role.

Conclusion This study suggests that despite UK guidelines and incentives to optimise physical healthcare, primary care fails to consistently deliver integrated biopsychosocial care for patients with SMI and OAD. Collaborative, personalised care that builds social capital and tailors support for self-management is needed, alongside service-level interventions to enhance access to healthcare for patients with comorbid SMI and OAD.

  • primary care
  • mental health
  • asthma
  • chronic airways disease

Data availability statement

No data are available. This a qualitative database and to protect anonymity of the participants, the data is not available publically, even in an anonymised complete format. Reasonable requests to discuss explanatory quotes with the lead researcher may be made.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

No data are available. This a qualitative database and to protect anonymity of the participants, the data is not available publically, even in an anonymised complete format. Reasonable requests to discuss explanatory quotes with the lead researcher may be made.

View Full Text

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Twitter @dclovesGP

  • Contributors CM is the responsible for the overall content and is guarantor for the work. All authors have fulfilled the four ICMJE criteria for authorship. Original conception and design and writing of the study protocol (CM, JH, HT, EW, BD). Ethical approvals (CM, BD, NW). Acquisition of the data (BD, NW, ND, CM, EW), analysis and interpretation of the data (all authors). Drafting the work (all authors). Final Approval of the version to be published (all authors). Agreement to be accountable for all aspects to the work (all authors). Integrated stakeholder and PPIE work by CM, NZ, ND, BD.

  • Funding Grant funded by the Clare Wand Fund (BMA). The research was also part-funded by the NIHR CLAHRC Yorkshire and Humber. www.clahrc-yh.nihr.ac.uk.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.